Status:
COMPLETED
Follow-Up of Bladder Cancer Patients From the New England Study of Environment and Health
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Bladder Cancer
Eligibility:
All Genders
30-79 years
Brief Summary
Background: * Bladder cancer often recurs after treatment and patient survival varies greatly. * More knowledge is needed about factors that can help identify patients who are at greater risk of dise...
Detailed Description
Background: * Bladder cancer is a highly recurrent disease with substantial variability in survival. * Patients currently undergo repeated cystoscopy for many years after diagnosis. * There is a need...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- With the exceptions noted below, all bladder cancer patients who participated in the NESEH and were residents of ME when first diagnosed with bladder cancer will be eligible for this feasibility study. Patients were eligible for the NESEH if they met the following criteria:
- 30-79 years old at initial diagnosis
- Newly diagnosed with histologically-confirmed carcinoma of the urinary bladder (including carcinoma in situ) between September 1, 2001 and October 31, 2004
- EXCLUSION CRITERIA:
- We will exclude from the feasibility study the following NESEH case participants:
- 44 bladder cancer patients (7 percent) first diagnosed at one of seven hospitals located in remote areas of ME (Aroostook Medical Center, Calais Regional Hospital, Cary Medical Center, Down East Community Hospital, Houlton Regional Hospital, Northern Maine Medical Center, and Mount Desert Hospital); this is for cost considerations;
- Patients diagnosed fewer than 5 years before the feasibility study begins (i.e., after 2003)
Exclusion
Key Trial Info
Start Date :
October 17 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2020
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT00776178
Start Date
October 17 2008
End Date
March 31 2020
Last Update
April 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute (NCI), 9000 Rockville Pike
Bethesda, Maryland, United States, 20892